Pictet Asset Management Holding SA

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1993888 CAROUGE, V8

Position in VRTX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$267,864,136

+$117,126,075 QoQ

Shares Held

539,255

+59.7% QoQ

Ownership

0.213%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#58

of 1,732 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 82% Shared 0% None 18%

Healthcare · as of Jun 30, 2026

Pictet Asset Management Holding SA holds $3,949,485,019 across 130 Biotechnology names. VRTX ranks #1 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	539,255	$267,864,136
2	RVMD	Revolution Medicines, Inc.	1,014,894	$190,069,348
3	ARGX	Argenx SE	198,282	$183,960,091
4	INSM	INSMED Inc	1,220,353	$130,114,036
5	IONS	Ionis Pharmaceuticals Inc	1,596,998	$126,625,971
6	ROIV	Roivant Sciences Ltd.	3,468,340	$122,744,552
7	BBIO	BridgeBio Pharma, Inc.	1,448,126	$107,856,424
8	RYTM	Rhythm Pharmaceuticals, Inc.	957,785	$106,342,868

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$267,864,136	539,255	+59.7%	Shares	Sole	2026-07-30
2026-03-31	$150,738,061	337,569	-55.1%	Shares	Sole	2026-04-22
2025-12-31	$341,119,398	752,425	-4.9%	Shares	Sole	2026-01-29
2025-09-30	$309,966,611	791,458	+7.6%	Shares	Sole	2025-11-18
2025-06-30	$327,587,954	735,822	+11.3%	Shares	Sole	2025-08-13
2025-03-31	$320,556,681	661,187	+27.2%	Shares	Sole	2025-05-05
2024-12-31	$209,270,303	519,668	+0.3%	Shares	Sole	2025-02-12
2024-09-30	$240,912,835	518,003	-8.1%	Shares	Sole	2024-11-12
2024-06-30	$264,056,224	563,356	-43.6%	Shares	Sole	2024-08-13
2024-03-31	$417,296,874	998,294	-7.7%	Shares	Sole	2024-05-14
2023-12-31	$439,866,806	1,081,046	+2.1%	Shares	Sole	2024-02-13
2023-09-30	$368,192,328	1,058,815	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.